An investigation for investors in NYSE:GEN shares was announced over potential breaches of fiduciary duties by certain Genesis Healthcare directors.
Investors who purchased shares of Genesis Healthcare Inc (NYSE:GEN) have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain Genesis Healthcare directors breached their fiduciary duties.
Genesis Healthcare Inc reported that its annual Total Revenue rose from over $4.76 billion in 2014 to over $5.61 billion in 2015 while its Net Loss increased from $239.94 million in 2014 to $424.98 million in 2015. Shares of Genesis Healthcare Inc (NYSE:GEN) declined from as high as $9.22 per share in January 2015 to as low as $1.42 per share in February 2016.
On June 6, 2016, NYSE:GEN shares closed at $1.86 per share.
Those who purchased NYSE:GEN shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego